About this trial
Elderly patients undergoing minimally invasive gastrointestinal tumor surgery face complex postoperative pain management due to age-related physiological decline and surgical particularities, where traditional opioids are prone to adverse effects. Our study investigates the clinical analgesic efficacy of ultrasound-guided transversus abdominis plane block (TAPB) in these patients, focusing on analgesic quality, delirium incidence, opioid consumption, and postoperative recovery indicators. This evaluation aims to assess its clinical value and safety while providing evidence-based insights for optimizing perioperative analgesia protocols.
Eligibility criteria
Qualifiers
Elderly patients scheduled for elective minimally invasive gastrointestinal tumor surgery under general anesthesia
Age ≥65 years
American Society of Anesthesiologists (ASA) physical status classification ≤III
Body mass index (BMI) 18-30 kg/m²
Disqualifiers
Allergy to anesthetic agents
Preoperative chronic pain or chronic use of opioids/nonsteroidal anti-inflammatory drugs (NSAIDs)
Contraindications to regional blockade:Local infection at puncture site
There is cognitive impairment, which is determined based on Mini Mental State Examination (MMSE) scores below the standard threshold
Trial design
Treatments tested in this trial
- Transversus Abdominis Plane Block, TAPB